Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05774951 |
|---|---|
| Brief Title: | A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy (CAMBRIA-1) |
| First Submitted : | February 16, 2023 |
| First Submitted that Met QC Criteria : | March 7, 2023 |
| First Posted : | March 20, 2023 |
| Last Update Submitted that Met QC Criteria : | April 18, 2024 |
| Last Update Posted : | April 19, 2024 |